Cholangiocarcinoma: An emerging indication for photodynamic therapy

Photodiagnosis and Photodynamic Therapy

Volumn 6, Issue 2, 2009, Pages 84-92

  Allison, Ron R ^a   Zervos, Emmanuel ^a   Sibata, Claudio H ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Cholangiocarcinoma; Interlukin 6; PDT; Photodynamic therapy; Radiation therapy

Indexed keywords

AMINOLEVULINIC ACID; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARBOHYDRATE ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; GEMCITABINE; HEMATOPORPHYRIN DERIVATIVE; INTERLEUKIN 6; PHENACYL CHLORIDE; PHOTOFRIN; PHOTOSENSITIZING AGENT; TALAPORFIN; TEMOPORFIN; TUMOR MARKER;

BILE DUCT CARCINOMA; BILIARY TRACT DRAINAGE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CHOLANGITIS; CLINICAL RESEARCH; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DRUG TARGETING; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FLUORESCENCE IN SITU HYBRIDIZATION; HEMOBILIA; HUMAN; INOPERABLE CANCER; INTERMETHOD COMPARISON; LIVER ATROPHY; LIVER FAILURE; LIVER HYPERTROPHY; LIVER TRANSPLANTATION; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALIGNANT TRANSFORMATION; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL ANATOMY; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; STENT; TREATMENT INDICATION; TREATMENT OUTCOME;

BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; HUMANS; NEOPLASM STAGING; PHOTOCHEMOTHERAPY;

EID: 68349103178     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2009.05.001     Document Type: Review

References (56)

1. McCaughan Jr. J.S., Mertens B.F., Cho C., et al. Photodynamic therapy to treat tumors of the extrahepatic biliary ducts. A case report. Arch Surg 126 1 (1991) 111-113
2. Blechacz B., and Gores G.J. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 48 1 (2008) 308-321
3. Reddy S.B., and Patel T. Current approaches to the diagnosis and treatment of cholangiocarcinoma. Curr Gastroenterol Rep 8 1 (2006) 30-37
4. Kiesslich T., Wolkersdorfer G., Neureiter D., et al. Photodynamic therapy for non-resectable perihilar cholangiocarcinoma. Photochem Photobiol Sci 8 1 (2009) 23-30
5. Bismuth H., Nakache R., and Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 215 1 (1992) 31-38
6. Shaib Y., and El-Serag H.B. The epidemiology of cholangiocarcinoma. Semin Liver Dis 24 2 (2004) 115-125
7. Sell S., and Dunsford H.A. Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol 134 6 (1989) 1347-1363
8. Hodge D.R., Hurt E.M., and Farrar W.L. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 41 16 (2005) 2502-2512
9. Goydos J.S., Brumfield A.M., Frezza E., et al. Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker. Ann Surg 227 3 (1998) 398-404
10. Cheon Y.K., Cho Y.D., Moon J.H., et al. Diagnostic utility of interleukin-6 (IL-6) for primary bile duct cancer and changes in serum IL-6 levels following photodynamic therapy. Am J Gastroenterol 102 10 (2007) 2164-2170
11. Jarnagin W.R., Fong Y., DeMatteo R.P., et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234 4 (2001) 507-517 [discussion 517-9]
12. Baron T.H., Harewood G.C., Rumalla A., et al. A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol 2 3 (2004) 214-219
13. Halling K.C., and Kipp B.R. Fluorescence in situ hybridization in diagnostic cytology. Hum Pathol 38 8 (2007) 1137-1144
14. Patel A.H., Harnois D.M., Klee G.G., et al. The utility of CA19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 95 1 (2000) 204-207
15. Nehls O., Gregor M., and Klump B. Serum and bile markers for cholangiocarcinoma. Semin Liver Dis 24 2 (2004) 139-154
16. Slattery J.M., and Sahani D.V. What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma?. Oncologist 11 8 (2006) 913-922
17. Gleeson F.C., Rajan E., Levy M.J., et al. EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc 67 3 (2008) 438-443
18. Shim C.S., Cheon Y.K., Cha S.W., et al. Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment. Endoscopy 37 5 (2005) 425-433
19. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg 206 1 (2008) 57-65
20. Jarnagin W.R., and Shoup M. Surgical management of cholangiocarcinoma. Semin Liver Dis 24 2 (2004) 189-199
21. Zervos E.E., Pearson H., Durkin A.J., et al. In-continuity hepatic resection for advanced hilar cholangiocarcinoma. Am J Surg 188 5 (2004) 584-588
22. Lang H., Sotiropoulos G.C., Sgourakis G., et al. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg 208 2 (2009) 218-228
23. Aljiffry M., Abdulelah A., Walsh M., et al. Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature. J Am Coll Surg 208 1 (2009) 134-147
24. Rea D.J., Rosen C.B., Nagorney D.M., et al. Transplantation for cholangiocarcinoma: when and for whom?. Surg Oncol Clin N Am 18 2 (2009) 325-337
25. Heimbach J.K., Gores G.J., Haddock M.G., et al. Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 24 2 (2004) 201-207
26. Abu-Hamda E.M., and Baron T.H. Endoscopic management of cholangiocarcinoma. Semin Liver Dis 24 2 (2004) 165-175
27. Raijman I. Biliary and pancreatic stents. Gastrointest Endosc Clin N Am 13 4 (2003) 561-592 vii-viii
28. Kaassis M., Boyer J., Dumas R., et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc 57 2 (2003) 178-182
29. De Palma G.D., Galloro G., Siciliano S., et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc 53 6 (2001) 547-553
30. Chahal P., and Baron T.H. Endoscopic palliation of cholangiocarcinoma. Curr Opin Gastroenterol 22 5 (2006) 551-560
31. Saito H., Takada T., Miyazaki M., et al. Radiation therapy and photodynamic therapy for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 15 1 (2008) 63-68
32. 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 57 5 (2003) 1357-1365
33. Furuse J., Takada T., Miyazaki M., et al. Guidelines for chemotherapy of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 15 1 (2008) 55-62
34. Takada T., Miyazaki M., Miyakawa S., et al. Purpose, use, and preparation of clinical practice guidelines for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 15 1 (2008) 2-6
35. Allison R.R., Downie G.H., Cuenca R., et al. Photosensitizers in clinical PDT. Photodiag Photodyn Ther 1 1 (2004) 27-42
36. Mott J.L., and Gores G.J. Targeting IL-6 in cholangiocarcinoma therapy. Am J Gastroenterol 102 10 (2007) 2171-2172
37. Pahernik S.A., Dellian M., Berr F., et al. Distribution and pharmacokinetics of Photofrin in human bile duct cancer. J Photochem Photobiol B 47 1 (1998) 58-62
38. Kiesslich T., Berlanda J., Plaetzer K., et al. Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines. Photochem Photobiol Sci 6 6 (2007) 619-627
39. Ortner M.A., Liebetruth J., Schreiber S., et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 114 3 (1998) 536-542
40. Ortner M. Photodynamic therapy for cholangiocarcinoma. J Hepatobiliary Pancreat Surg 8 2 (2001) 137-139
41. Berr F., Wiedmann M., Tannapfel A., et al. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 31 2 (2000) 291-298
42. Rumalla A., Baron T.H., Wang K.K., et al. Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc 53 4 (2001) 500-504
43. Dumoulin F.L., Gerhardt T., Fuchs S., et al. Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. Gastrointest Endosc 57 7 (2003) 860-867
44. Wiedmann M., Caca K., Berr F., et al. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study. Cancer 97 11 (2003) 2783-2790
45. Harewood G.C., Baron T.H., Rumalla A., et al. Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma. J Gastroenterol Hepatol 20 3 (2005) 415-420
46. Witzigmann H., Berr F., Ringel U., et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg 244 2 (2006) 230-239
47. Kahaleh M., Mishra R., Shami V.M., et al. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. Clin Gastroenterol Hepatol 6 3 (2008) 290-297
48. Ortner M.E., Caca K., Berr F., et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 125 5 (2003) 1355-1363
49. Zoepf T., Jakobs R., Arnold J.C., et al. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol 100 11 (2005) 2426-2430
50. Zoepf T., Jakobs R., Rosenbaum A., et al. Photodynamic therapy with 5-aminolevulinic acid is not effective in bile duct cancer. Gastrointest Endosc 54 6 (2001) 763-766
51. Pereira S.P., Ayaru L., Rogowska A., et al. Photodynamic therapy of malignant biliary strictures using meso-tetrahydroxyphenylchlorin. Eur J Gastroenterol Hepatol 19 6 (2007) 479-485
52. Prasad G.A., Wang K.K., Baron T.H., et al. Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma. Clin Gastroenterol Hepatol 5 6 (2007) 743-748
53. Berr F., Tannapfel A., Lamesch P., et al. Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma. J Hepatol 32 2 (2000) 352-357
54. Nanashima A., Yamaguchi H., Shibasaki S., et al. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study. J Gastroenterol 39 11 (2004) 1095-1101
55. Wiedmann M., Berr F., Schiefke I., et al. Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study. Gastrointest Endosc 60 1 (2004) 68-75
56. Zoepf T., Jakobs R., Arnold J.C., et al. Photodynamic therapy for palliation of nonresectable bile duct cancer-preliminary results with a new diode laser system. Am J Gastroenterol 96 7 (2001) 2093-2097